Borealis advancing sustainability medical devices with the Bornewables
The Protect VL project was born out of a vision to reduce the environmental footprint of medical devices
The Protect VL project was born out of a vision to reduce the environmental footprint of medical devices
AstraZeneca and Daiichi Sankyo’s Enhertu followed by THP showed an improved safety profile vs. standard of care
This outcome reflects Innoxel Lifesciences' ongoing commitment to maintaining the highest standards of quality, compliance, and regulatory excellence
Delivers robust earnings performance, successfully navigating a dynamic environment
Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thoracic cancers for two first-in-class ADCs
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation
The supply of these goods is set to commence within the first quarter of FY26
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
Subscribe To Our Newsletter & Stay Updated